IP Library Assignment 055181/0119
Patent Assignment
Reel/Frame 055181/0119

Assignment of Assignor's Interest

Recorded: 2021-02-08 Pages: 10
Assignor
Assignee
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
SUITE #5-204, 23 LINE TREE BAY AVENUE, P.O. BOX 2547, GRAND CAYMAN, KY1-1104, CAYMAN ISLANDS
Covered Properties (23)
Chimeric Antigen Receptor Cells for Treating Solid Tumor
Reducing Immune Tolerance Induced by PD-L1
Patent: 9,572,837 →
Application: 15/093,643 →
Publication: US 2016/0256488
Reducing Immune Tolerance Induced by PD-L1
Application: 15/373,012 →
Publication: US 2017/0096638
Use of Chimeric Antigen Receptor Modified Cells to Treat Cancer
Patent: 9,932,405 →
Application: 15/685,670 →
Publication: US 2017/0355776
Humanized Anti-CD19 Antibody and Use Thereof with Chimeric Antigen Receptor
Application: 15/876,538 →
Publication: US 2018/0153977
Use of Chimeric Antigen Receptor Modified Cells to Treat Cancer
Application: 15/897,743 →
Publication: US 2018/0179289
Activation and Expansion of T Cells
Application: 15/939,402 →
Publication: US 2018/0223255
Use of Chimeric Antigen Receptor Modified Cells to Treat Cancer
Application: 15/942,112 →
Publication: US 2018/0222995
Chimeric Antigen Receptor Cell Preparation and Uses Thereof
Application: 15/992,833 →
Publication: US 2018/0346876
Lymphocyte Cell Lines and Uses Thereof
Application: 16/023,310 →
Publication: US 2019/0000878
Modified Cell Expansion and Uses Thereof
Application: 16/146,218 →
Publication: US 2019/0216851
Chimeric antigen receptor (CAR) and T cell receptor (TCR) Modified T cells
Application: 16/157,545 →
Publication: US 2019/0125798
Modified Cell Expansion and Uses Thereof
Application: 16/387,166 →
Publication: US 2019/0314411
Reducing Immune Tolerance Induced by Pd-L1
Application: 16/404,349 →
Publication: US 2019/0316086
Modified Cell Expressing Therapeutic Agent and Uses thereof
Application: 16/445,965 →
Publication: US 2020/0155598
CAR T Therapy through Uses of Co-stimulation
Application: 16/552,521 →
Publication: US 2020/0071400
Modulation of Cell Function for Immunotherapy
Application: 16/555,198 →
Publication: US 2020/0069732
Use of Chimeric Antigen Receptor Modified Cells to Treat Autoimmune Disease
Application: 16/568,799 →
Publication: US 2020/0078403
Humanized Anti-CD19 Antibody and Use Thereof with Chimeric Antigen Receptor
Application: 16/600,064 →
Publication: US 2020/0030424
Modified Cell Expansion and Uses Thereof
Application: 16/961,418 →
Publication: US 2022/0265708
Use of Chimeric Antigen Receptor Modified Cells to Treat Cancer
Application: 16/997,553 →
Publication: US 2020/0385484
Reducing Immune Tolerance Induced by PD-L1
Application: 17/101,780 →
Publication: US 2021/0079349
Modified Cell Expansion and Uses Thereof
Application: 17/108,076 →
Publication: US 2021/0077532
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 7, 2016
From: WU, ZHAO
To: SHANGHAI SIDANSAI BIOTECHNOLOGY CO., LTD
Reel/Frame 038387/0579 →
Assignment of Assignor's Interest Dec 15, 2016
From: WU, ZHAO
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 040637/0712 →
Assignment of Assignor's Interest Aug 24, 2017
From: XIAO, LEI; WU, ZHAO; PU, CHENGFEI; CAO, ZHIYUAN
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 043390/0603 →
Assignment of Assignor's Interest Jan 22, 2018
From: WU, ZHAO; LIU, ZHIGANG; XIAO, LEI; PU, CHENGFEI
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 044688/0078 →
Assignment of Assignor's Interest Mar 29, 2018
From: WU, ZHAO; XIAO, LEI; PU, CHENGFEI
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 045382/0155 →
Assignment of Assignor's Interest May 30, 2018
From: XIAO, LEI; CAO, ZHIYUAN; PU, CHENGFEI; WU, ZHAO
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 045936/0725 →
Assignment of Assignor's Interest Jun 29, 2018
From: XIAO, LEI; CAO, ZHIYUAN; PU, CHENGFEI; WU, ZHAO
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 046461/0934 →
Assignment of Assignor's Interest Sep 28, 2018
From: XIAO, LEI; CAO, ZHIYUAN; PU, CHENGFEI; WU, ZHAO
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 047008/0895 →
Assignment of Assignor's Interest Oct 11, 2018
From: XIAO, LEI; MAO, LI; WU, ZHAO
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 047134/0899 →
Assignment of Assignor's Interest Apr 17, 2019
From: XIAO, LEI; CAO, ZHIYUAN; PU, CHENGFEI; SUN, HE
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 048915/0723 →
Assignment of Assignor's Interest May 8, 2019
From: WU, ZHAO
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 049110/0206 →
Assignment of Assignor's Interest Jun 19, 2019
From: XIAO, LEI; CAO, ZHIYUAN; PU, CHENGFEI; SUN, HE
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 049522/0310 →
Change of Name Aug 9, 2019
From: SHANGHAI SIDANSAI BIOTECHNOLOGY CO., LTD.
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 050018/0415 →
Assignment of Assignor's Interest Aug 27, 2019
From: CAO, ZHIYUAN; PU, CHENGFEI; XIAO, LEI; WU, ZHAO
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 050184/0367 →
Assignment of Assignor's Interest Aug 29, 2019
From: CAO, ZHIYUAN; PU, CHENGFEI; XIAO, LEI; WU, ZHAO
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 050212/0529 →
Assignment of Assignor's Interest Nov 12, 2019
From: XIAO, LEI; PU, CHENGFEI; WU, ZHAO; LU, LINRONG
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.; ZHEJIANG UNIVERSITY
Reel/Frame 050978/0830 →
Assignment of Assignor's Interest Feb 13, 2020
From: XIAO, LEI; WU, ZHAO; PU, CHENGFEI; CAO, ZHIYUAN
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 051807/0316 →
Assignment of Assignor's Interest Jul 19, 2020
From: XIAO, LEI; WU, ZHAO; PU, CHENGFEI; CAO, ZHIYUAN
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 053247/0414 →
Assignment of Assignor's Interest Mar 15, 2024
From: INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
To: INNOVATIVE CELLULAR THERAPEUTICS, INC.; INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
Reel/Frame 066789/0558 →
Assignment of Assignor's Interest May 1, 2025
From: XIAO, LEI; PU, CHENGFEI; CAO, ZHIYUAN
To: INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
Reel/Frame 070994/0355 →
Assignment of Assignor's Interest Jul 24, 2025
From: INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
To: INNOVATIVE CELLULAR THERAPEUTICS, INC.; INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
Reel/Frame 071825/0430 →
Assignment of Assignor's Interest Oct 14, 2025
From: WU, ZHAO; LIU, ZHIGANG; XIAO, LEI; PU, CHENGFEI
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 072558/0762 →
Assignment of Assignor's Interest Oct 14, 2025
From: XIAO, LEI; PU, CHENGFEI; CAO, ZHIYUAN; SUN, HE
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 072557/0725 →